2018
DOI: 10.26434/chemrxiv.6394430.v1
|View full text |Cite
Preprint
|
Sign up to set email alerts
|

Design and Evaluation of Heterobivalent PAR1–PAR2 Ligands as Antagonists of Calcium Mobilization

Abstract: A novel class of bivalent ligands targeting putative Protease-Activated Receptor (PAR) heteromers has been prepared based upon reported antagonists for the subtypes PAR1 and PAR2. Modified versions of the PAR1 antagonist RWJ-58259 containing alkyne adapters were connected via cycloaddition reactions to azide-capped polyethylene glycol (PEG) spacers attached to imidazopyridazine-based PAR2 antagonists. Initial studies of the PAR1–PAR2 antagonists indicated that they inhibited G alpha q-mediated calcium mobiliza… Show more

Help me understand this report
View published versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2019
2019
2019
2019

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 39 publications
0
1
0
Order By: Relevance
“…PARs are known to participate in diverse processes, including thrombosis, pain, and inflammation (Mrozkova et al, 2016;Crilly et al, 2012;McCulloch et al, 2018;Heuberger et al 2019). Notably, PAR2 is being investigated as a therapeutic target for pain and inflammation and many modulators of PAR2 have been developed so far (Ramachandran et al 2012;Ferrell et al, 2008;Yau et al, 2013;Yau et al 2016;Jiang et al, 2018;Lee et al, 2019;Majewski et al, 2018).…”
Section: Supplementarymentioning
confidence: 99%
“…PARs are known to participate in diverse processes, including thrombosis, pain, and inflammation (Mrozkova et al, 2016;Crilly et al, 2012;McCulloch et al, 2018;Heuberger et al 2019). Notably, PAR2 is being investigated as a therapeutic target for pain and inflammation and many modulators of PAR2 have been developed so far (Ramachandran et al 2012;Ferrell et al, 2008;Yau et al, 2013;Yau et al 2016;Jiang et al, 2018;Lee et al, 2019;Majewski et al, 2018).…”
Section: Supplementarymentioning
confidence: 99%